2024年11月11日,生物技术公司Adaptive Biotechnologies Corporation(ADPT)盘中股价出现大幅上涨,最高涨幅达9.28%。据报道,截至收盘该公司股价报收于6.19美元,成交量2.7134万股。
Adaptive Biotechnologies是一家利用免疫系统生物学改变疾病诊断和治疗的公司。其产品clonoSEQ可用于检测和监测多种癌症患者的微小残留病灶。资料显示,该公司最新季度实现营收4644万美元,净亏损3207万美元。
尽管并无具体新闻直接解释Adaptive Biotechnologies当日股价大涨的原因,但分析人士猜测,这可能与公司最新的财报数据或产品进展情况有关。不过具体推动力仍有待进一步观察和分析。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.